Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

HIV-1 evolutionary dynamics under non-suppressive, 2nd-line protease-inhibitor containing antiretroviral therapy

View ORCID ProfileSteven A. Kemp, Oscar Charles, Anne Derache, Collins Iwuji, John Adamson, Katya Govender, Tulio de Oliveira, Nonhlanhla Okesola, Francois Dabis, Darren P. Martin, Deenan Pillay, Richard A. Goldstein, View ORCID ProfileRavindra K. Gupta on behalf of the French National Agency for AIDS and Viral Hepatitis Research (ANRS) 12249 Treatment as Prevention (TasP) Study Group
doi: https://doi.org/10.1101/2021.04.09.21254592
Steven A. Kemp
1Division of Infection & Immunity, University College London, London, UK
3Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Steven A. Kemp
  • For correspondence: sk2137{at}cam.ac.uk Rkg20{at}cam.ac.uk
Oscar Charles
1Division of Infection & Immunity, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Derache
2Africa Health Research Institute, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Collins Iwuji
2Africa Health Research Institute, Durban, South Africa
5Research Department of Infection and Population Health, University College London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Adamson
2Africa Health Research Institute, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katya Govender
2Africa Health Research Institute, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tulio de Oliveira
2Africa Health Research Institute, Durban, South Africa
6KRISP - KwaZulu-Natal Research and Innovation Sequencing Platform, UKZN, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nonhlanhla Okesola
2Africa Health Research Institute, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Dabis
7INSERM U1219-Centre Inserm Bordeaux Population Health, Université de Bordeaux, France
8Université de Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darren P. Martin
9Department of Integrative Biomedical Sciences, University of Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deenan Pillay
1Division of Infection & Immunity, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard A. Goldstein
1Division of Infection & Immunity, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ravindra K. Gupta
2Africa Health Research Institute, Durban, South Africa
3Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ravindra K. Gupta
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: April 2021 to June 2025

AbstractFullPdf
Apr 2021456675
May 2021126119
Jun 2021100120
Jul 20215829
Aug 20212922772
Sep 2021985739
Oct 2021711934
Nov 202173745
Dec 202161336
Jan 202247622
Feb 2022115741
Mar 20221872742
Apr 2022961136
May 202279519
Jun 202266479
Jul 202240077
Aug 20224156
Sep 20225068
Oct 20223937
Nov 20223432
Dec 202221617
Jan 20231029
Feb 20231374
Mar 20232755
Apr 20232983
May 202318712
Jun 2023774
Jul 20231043
Aug 202321135
Sep 20231244
Oct 20231262
Nov 2023211430
Dec 2023710
Jan 20241013
Feb 20242257
Mar 202421149
Apr 2024726
May 202410815
Jun 20241948
Jul 202420215
Aug 2024231010
Sep 2024191113
Oct 202411117
Nov 2024111114
Dec 2024111412
Jan 202516414
Feb 20252014722
Mar 20255115928
Apr 2025281435
May 2025311628
Jun 2025644428
Back to top
PreviousNext
Posted August 13, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
HIV-1 evolutionary dynamics under non-suppressive, 2nd-line protease-inhibitor containing antiretroviral therapy
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
HIV-1 evolutionary dynamics under non-suppressive, 2nd-line protease-inhibitor containing antiretroviral therapy
Steven A. Kemp, Oscar Charles, Anne Derache, Collins Iwuji, John Adamson, Katya Govender, Tulio de Oliveira, Nonhlanhla Okesola, Francois Dabis, Darren P. Martin, Deenan Pillay, Richard A. Goldstein, Ravindra K. Gupta
medRxiv 2021.04.09.21254592; doi: https://doi.org/10.1101/2021.04.09.21254592
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
HIV-1 evolutionary dynamics under non-suppressive, 2nd-line protease-inhibitor containing antiretroviral therapy
Steven A. Kemp, Oscar Charles, Anne Derache, Collins Iwuji, John Adamson, Katya Govender, Tulio de Oliveira, Nonhlanhla Okesola, Francois Dabis, Darren P. Martin, Deenan Pillay, Richard A. Goldstein, Ravindra K. Gupta
medRxiv 2021.04.09.21254592; doi: https://doi.org/10.1101/2021.04.09.21254592

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • HIV/AIDS
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)